{"id":7491,"date":"2025-11-20T11:23:16","date_gmt":"2025-11-20T17:23:16","guid":{"rendered":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/"},"modified":"2025-11-20T11:23:16","modified_gmt":"2025-11-20T17:23:16","slug":"missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2","status":"publish","type":"post","link":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/","title":{"rendered":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion"},"content":{"rendered":"

\"Clinicians<\/p>\n

Missouri is among three states challenging current federal regulations around mifepristone, a medication used to induce an abortion (Natalie Behring\/Getty Images).<\/p>\n

Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration\u2019s recent decision to approve a new generic brand of mifepristone, her first foray into a lawsuit filed by her predecessor to limit access to medication abortion nationwide.<\/span><\/p>\n

In September the FDA approved a new <\/span>generic form of mifepristone<\/span><\/a>, bringing the total approved manufacturers to three.<\/span><\/p>\n

This federal approval, which <\/span>drew the ire of anti-abortion groups<\/span><\/a>, came after Health and Human Services Secretary Robert F. Kennedy Jr. promised U.S. Sen. Josh Hawley, a Republican from Missouri, that his agency would conduct a \u201ccomplete review\u201d of mifepristone.\u00a0<\/span><\/p>\n

\u201cIf the FDA is reevaluating the brand-name drug\u2019s safety, then it needs to stop rubber-stamping new mail-order generic versions before more women are hurt,\u201d Hanaway said in a statement Thursday.<\/span><\/p>\n

The new FDA approval will make medication abortions more accessible, Hanaway argues.<\/span><\/p>\n

\u201cThe supply of mifepristone will increase, the cost will decrease and the number of chemical abortions will rise\u2026 across the nation,\u201d the new court filing reads.<\/span><\/p>\n

The lawsuit demands the federal government restore its previous restrictions on mifepristone by requiring three in-person doctor visits, reducing the gestational period during which the medication can be taken from 10 weeks to seven and rolling back recent federal policy that allowed for the mailing of mifepristone and allowed for prescriptions to be made online or through pharmacies.<\/span><\/p>\n

Medication abortion \u2014<\/span> used in about two-thirds of abortions in the U.S. <\/span><\/a>\u2014\u00a0requires two kinds of pills. The first, mifepristone, causes the embryo or fetus to stop growing and detach from the uterine wall, ending the pregnancy. The second, misoprostol, causes the uterus to expel the pregnancy tissue. Both medications are also used to treat miscarriages.<\/span><\/p>\n

\u201cFor Missouri and other states with strong protections for unborn life and maternal health, the widespread mail-order distribution of mifepristone directly undermines state law and burdens state hospitals, emergency rooms, and taxpayers,\u201d Hanaway said in her statement Thursday.<\/span><\/p>\n

The FDA states that <\/span>mifepristone is safe to use if taken as directed<\/span><\/a> in the first trimester of pregnancy.\u00a0<\/span><\/p>\n

Bleeding and cramping are <\/span>expected side effects.<\/span><\/a> More rarely, there can be hemorrhaging and infection. Those prescribed mifepristone are urged to call their doctor <\/span>if they experience heavy bleeding, abdominal pain or a fever. <\/span><\/a>This guidance also applies to those who recently underwent surgical abortions, experienced miscarriages or delivered a baby.<\/span><\/p>\n

Since the medication was approved for use nearly three decades ago, the FDA has reported only <\/span>32 deaths associated with mifepristone<\/span><\/a>. The report evaluates data from 5.9 million women who took mifepristone between 2000 and 2022. Of the three dozen deaths, 11 were the result of sepsis, 20 were homicides and two were suicides.<\/span><\/p>\n

\n

Missouri still among worst states for infant, maternal health as new Medicaid cuts loom<\/a><\/p>\n<\/blockquote>\n

Hanaway stepped into the legal challenge to mifepristone first filed by her predecessor, Andrew Bailey. The federal lawsuit challenging the safety of mifepristone was taken up by the <\/span>attorneys general of Missouri, Idaho and Kansas <\/span><\/a>last year after the <\/span>U.S. Supreme Court rejected the original lawsuit<\/span><\/a>, saying the anti-abortion doctors and medical organizations in Texas who brought the original case didn\u2019t have the standing to sue.\u00a0<\/span><\/p>\n

The case was recently moved from a federal court in Texas <\/span>to the eastern district of Missouri in St. Louis<\/span><\/a> after a federal judge in Texas said he no longer had jurisdiction over the plaintiffs. A court date has not yet been set.<\/span><\/p>\n

Despite voters enshrining the right to abortion in the Missouri Constitution last year, <\/span>medication abortion is inaccessible<\/span><\/a> through Planned Parenthood clinics in Missouri.\u00a0\u00a0\u00a0<\/span><\/p>\n

A Jackson County judge is currently weighing whether to keep in place two state regulations that Planned Parenthood says are preventing its providers from performing medication abortions in Missouri.\u00a0\u00a0\u00a0<\/span><\/p>","protected":false},"excerpt":{"rendered":"

Missouri is among three states challenging current federal regulations around mifepristone, a medication used to induce an abortion (Natalie Behring\/Getty Images). Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration\u2019s recent decision to approve a new generic brand of mifepristone, her first foray into a…<\/p>\n","protected":false},"author":2,"featured_media":7492,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nMissouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com\" \/>\n<meta property=\"og:description\" content=\"Missouri is among three states challenging current federal regulations around mifepristone, a medication used to induce an abortion (Natalie Behring\/Getty Images). Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration\u2019s recent decision to approve a new generic brand of mifepristone, her first foray into a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\" \/>\n<meta property=\"og:site_name\" content=\"WestplexNews.com\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T17:23:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/missouriindependent.com\/wp-content\/uploads\/2025\/09\/mifepristone-tablets.jpeg\" \/>\n<meta name=\"author\" content=\"Brad Hildebrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brad Hildebrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\"},\"author\":{\"name\":\"Brad Hildebrand\",\"@id\":\"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0\"},\"headline\":\"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion\",\"datePublished\":\"2025-11-20T17:23:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\/\/westplexnews.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\",\"url\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\",\"name\":\"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com\",\"isPartOf\":{\"@id\":\"https:\/\/westplexnews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg\",\"datePublished\":\"2025-11-20T17:23:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage\",\"url\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg\",\"contentUrl\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/westplexnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/westplexnews.com\/#website\",\"url\":\"https:\/\/westplexnews.com\/\",\"name\":\"WestplexNews.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/westplexnews.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/westplexnews.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/westplexnews.com\/#organization\",\"name\":\"WestplexNews.com\",\"url\":\"https:\/\/westplexnews.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png\",\"contentUrl\":\"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png\",\"width\":690,\"height\":242,\"caption\":\"WestplexNews.com\"},\"image\":{\"@id\":\"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0\",\"name\":\"Brad Hildebrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/westplexnews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g\",\"caption\":\"Brad Hildebrand\"},\"sameAs\":[\"http:\/\/Westplexnews.com\"],\"url\":\"https:\/\/westplexnews.com\/index.php\/author\/bradh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/","og_locale":"en_US","og_type":"article","og_title":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com","og_description":"Missouri is among three states challenging current federal regulations around mifepristone, a medication used to induce an abortion (Natalie Behring\/Getty Images). Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration\u2019s recent decision to approve a new generic brand of mifepristone, her first foray into a...","og_url":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/","og_site_name":"WestplexNews.com","article_published_time":"2025-11-20T17:23:16+00:00","og_image":[{"url":"https:\/\/missouriindependent.com\/wp-content\/uploads\/2025\/09\/mifepristone-tablets.jpeg","type":"","width":"","height":""}],"author":"Brad Hildebrand","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Brad Hildebrand","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#article","isPartOf":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/"},"author":{"name":"Brad Hildebrand","@id":"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0"},"headline":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion","datePublished":"2025-11-20T17:23:16+00:00","mainEntityOfPage":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/"},"wordCount":657,"publisher":{"@id":"https:\/\/westplexnews.com\/#organization"},"image":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage"},"thumbnailUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/","url":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/","name":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion - WestplexNews.com","isPartOf":{"@id":"https:\/\/westplexnews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage"},"image":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage"},"thumbnailUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg","datePublished":"2025-11-20T17:23:16+00:00","breadcrumb":{"@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#primaryimage","url":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg","contentUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/11\/mifepristone-tablets-sCSRio.jpg","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/westplexnews.com\/index.php\/2025\/11\/20\/missouri-challenges-fda-approval-of-new-generic-mifepristone-in-push-to-limit-abortion-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/westplexnews.com\/"},{"@type":"ListItem","position":2,"name":"Missouri challenges FDA approval of new generic mifepristone in push to limit abortion"}]},{"@type":"WebSite","@id":"https:\/\/westplexnews.com\/#website","url":"https:\/\/westplexnews.com\/","name":"WestplexNews.com","description":"","publisher":{"@id":"https:\/\/westplexnews.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/westplexnews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/westplexnews.com\/#organization","name":"WestplexNews.com","url":"https:\/\/westplexnews.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/","url":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png","contentUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png","width":690,"height":242,"caption":"WestplexNews.com"},"image":{"@id":"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0","name":"Brad Hildebrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/westplexnews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g","caption":"Brad Hildebrand"},"sameAs":["http:\/\/Westplexnews.com"],"url":"https:\/\/westplexnews.com\/index.php\/author\/bradh\/"}]}},"_links":{"self":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts\/7491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/comments?post=7491"}],"version-history":[{"count":0,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts\/7491\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/media\/7492"}],"wp:attachment":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/media?parent=7491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/categories?post=7491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/tags?post=7491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}